Feed DOCS
DO

Doximity DOCS · NYSE

$31.45 +1.53% (+$0.48)

Summary

80 / 100 · Bulios Score

What speaks for it

  • Out of every 100 USD of revenue, 25 USD is left as net profit.
  • Revenue grew by 18% a year over the last 3 years.
  • It holds more cash than debt: $273.6M against $9.67M.
  • It earns 15 USD a year on every 100 USD of invested capital.

What to watch

  • You pay 33.1 USD for 1 USD of yearly profit, a lot for its sector.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Fairly priced
Bulios Fair Price
Current price $31.45
5-year average P/E 53.8 39% lower
P/E today 33.1
Medical - Healthcare Information Services industry median
P/E today 33.1

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 33.1 USD for 1 USD of yearly profit. Over the last five years it was 53.8 USD on average.

Valuation in detail

Is it growing?

Yes, fast

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 37% a year over 5 years. Over the last 3 years it grew by 18% a year. For the next fiscal year analysts expect revenue to grow by 13%. Earnings per share grew by 17% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 USD of revenue goes

Net profit, industry median (Medical - Healthcare Information Services) 4.7 USD

Out of every 100 USD of revenue, 25 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

It could repay all its debt from a single year of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Neutral

Today's price within the analysts' price targets

The average target of $27.73 is 12% below today's price. 38% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2026

By product

By region

The company reports no revenue by region.

Subscription brings in 94% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.